Results from the first controlled trial on #hydroxychloroquine for #COVID19 are out--but the study is really too small for us to conclude much of anything. #coronavirushttps://www.forbes.com/sites/tarahaelle/2020/03/25/chloroquine-use-for-covid-19-shows-no-benefit-in-first-small-but-limited-controlled-trial/#6210a4cc4c86 …
-
-
Replying to @tarahaelle
I think it’s important and responsible journalism to highlight the following as lives are at stake: 1. The Chinese study was performed several weeks earlier before the French study. 2. The dosages administered and timeframe were significantly different.
1 reply 1 retweet 4 likes -
Replying to @lunarstudio @tarahaelle
3. The Chinese study had roughly the same amount of patients as the French study. 4. Dosages were at 400 Mg 1x/day for almost half the total time as the French study which administered at 200 mg 3X/day (total of 600 mg) for 10 days.
1 reply 1 retweet 2 likes -
Replying to @lunarstudio @tarahaelle
5. Other factors to consider during the earlier Chinese testing are not listed. Ie. Did they have ventilators, IV supplements, what other meds were they administering or not? 6. The French scientist was aware of this poorly designed initial Chinese study.
1 reply 1 retweet 0 likes -
Replying to @lunarstudio @tarahaelle
the design of the chinesse trial is way better than the one of the French. Randomized, continuous following and similar number of patients.
2 replies 0 retweets 0 likes
And results still not published, as far as I've been able to find.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.